Hanon Systems Releases of 2025/26 ESG Report
- Provides English translation of its ninth sustainability report, offering global stakeholders access to annual ESG achievements and sustainability strategies, strengthens ESG governance framework with plans to establish an ESG Steering Committee in the second half of 2026
The report provides global stakeholders with an overview of the company's environmental, social, and governance (ESG) initiatives, performance, and risk management achievements, including the transition toward electrification and the growing adoption of Software-Defined Vehicles (SDVs).
To further advance its ESG governance framework, Hanon Systems plans to establish an integrated management systems based on an ESG Steering Committee in the second half of 2026, strengthening company-wide collaboration and execution.
The report is available on the company's website.
About Hanon Systems
Hanon Systems, founded in 1986, is a global leader in thermal management solutions. In January 2025, it became a subsidiary of Hankook & Company Group. Its offering includes a wide range of solutions in the areas of heating, ventilation and air conditioning, powertrain cooling, compressor, fluid transport, and electronics and fluid pressure. The company currently operates 50 manufacturing sites and three regional innovation centers and employs more than 20,000 people across 21 countries. To learn more, visit hanonsystems.com.
Follow Hanon Systems:
LinkedIn: https://www.linkedin.com/company/hanonsystems
YouTube: https://www.youtube.com/channel/UC6bSZ7NMg7LPhXDyTOMwebQ/feed
View original content to download multimedia:https://www.prnewswire.com/news-releases/hanon-systems-releases-of-202526-esg-report-302839837.html
SOURCE Hanon Systems
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Repeat Orders Drive Zoomlion's International Concrete Machinery Growth
- FICG Strengthens ASEAN Presence Through Strategic Partnerships with AME and JTC
- CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share